Sector: Real Estate | Industry: Specialized REITs |
Company Contact | |
Address: | 180 Dundas St W Suite 1100 TORONTO ON M5G 1Z8 |
Tel: | N/A |
Website: | https://www.nwhreit.com |
IR: | See website |
Key People | ||
Craig D. Mitchell President, Chief Executive Officer | Karen Martin Interim Chief Financial Officer | Mike Brady Executive Vice President, General Counsel |
Peter Riggin Chief Administrative Officer | Jan Krizan Head of Global Funds |
Business Overview |
Northwest Healthcare Properties Real Estate Investment Trust is a Canada-based open-ended real estate investment trust. The Company operates in the healthcare real estate industry segment. Its businesses include funds management, asset management, and development. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings, and life sciences, research, and education. It provides a portfolio of international healthcare real estate infrastructure comprised of interests in a diversified portfolio of approximately 231 income-producing properties and 18.5 million square feet of gross leasable area located throughout markets in Canada, the United States, Brazil, Europe, Australia, and New Zealand. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies. |
Financial Overview |
For the fiscal year ended 31 December 2023, NorthWest Healthcare Properties REIT revenues increased 12% to C$508M. Net loss totaled C$347.7M vs. income of C$64.3M. Revenues reflect Americas segment increase of 16% to C$250.7M, Europe segment increase of 16% to C$102.8M. Net loss reflects Americas segment loss totaling C$21.4M vs. income of C$27.8M, Europe segment income decrease of 76% to C$10.2M. |
Employees: | 275 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $5,053M as of Dec 31, 2023 |
Annual revenue (TTM): | $508.00M as of Dec 31, 2023 |
EBITDA (TTM): | $330.32M as of Dec 31, 2023 |
Net annual income (TTM): | -$347.69M as of Dec 31, 2023 |
Free cash flow (TTM): | -$44.08M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $3,855M as of Dec 31, 2023 |
Shares outstanding: | 245,577,685 as of Mar 18, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |